Hepatitis C after renal transplantation;Hepatite C apres greffe renale

Presse Medicale

Volumn 27, Issue 14, 1998, Pages 684-688

  Rostaing, L ^a   Izopet, J ^a   Modesto Segonds, A ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMANTADINE; RIBAVIRIN; URSODEOXYCHOLIC ACID; VIRUS RNA;

CHRONIC ACTIVE HEPATITIS; DIALYSIS; GRAFT REJECTION; HEPATITIS C; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER CIRRHOSIS; PREVALENCE; REVIEW; VIRUS LOAD; BIOPSY; CHRONIC KIDNEY FAILURE; IMMUNOSUPPRESSIVE TREATMENT; PATHOLOGY; POSTOPERATIVE COMPLICATION; RENAL REPLACEMENT THERAPY; VIROLOGY;

BIOPSY; HEPATITIS C; HUMANS; IMMUNOSUPPRESSION; INTERFERON-ALPHA; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RENAL DIALYSIS;

EID: 0032507481     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Parfrey PS, Forbes RDC, Hutchinson TA et al. The impact of renal transplantation on the course of hepatitis B liver disease. Transplantation 1985 ; 39:610-15.
2. Fornairon S, Pol S, Legendre C et al. The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. Transplantation 1996 ; 362:297-9.
3. Pol S, Romeo R, Zins B et al. Hepatitis C virus RNA in anti-HCV positive hemodialysed patients : significance and therapeutic implications. Kidney Int 1993 ; 44:1097-100.
4. Stempel CA, Lake J, Kuo G, Vincenti F. Hepatitis C- Its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993 ; 55:273-6.
5. Roth D, Zucker K, Cirocco R et al. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1994 ; 45:238-44.
6. Pereira BJG, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997 ; 51:981-99.
7. Choo Q, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genomen. Science 1989 ; 244:358-62.
8. Calabrese G, Vagelli G, Guaschino R, Gonella M. Transmission of anti-HCV within the household of hemodialysis patients. Lancet 1991 ; 338:1466.
9. Cendoroglo MN, Manzano SIR, Canziani MEEA. Envrionemental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit. Artif Organs 1995 ; 19:251-5.
10. Sampietro M, Badalamenti S, Salvadori S et al. High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit Evidence for nosocomial transmission of HCV. Kidney Int 1995 ; 47:911-17.
11. Caramelo C, Navas S, Alberola ML et al. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid. Nephron 1994 ; 66:470-3.
12. Hubmann R, Zazgornik J, Gabriel C, Garbeis B, Blauhut B. Hepatitis C virus. Does it penetrate the haemodialysis membrane ? PCR analysis of haemodialysis ultrafiltrate and whole blood. Nephrol Dial Transplant 1995 ; 10:541-2.
13. Huang CC, Wu MS, Lin DY, Liaw YF. The prevalence of hepatitis C virus antibodies in patients with continuous ambulatory peritoneal dialysis. Peril Dial Int 1992 ; 12:31-3.
14. Wolf PL, William D, Coplon N, Coulson AS. Low aspartate transaminase activity in serum of patients undergoing chronic hemodialysis. Clin Chem 1972 ; 18:567-73.
15. Simon N, Couroucé AM, Lemarrec N, Trepo C, Ducamp S. A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 1994 ; 46:504-11.
16. Natov SN, Pereira BJG. Hepatitis C infection in patients on dialysis. Semin Dial 1994 ; 7:360-8.
17. Simmonds P, Alberti A, Alter HJ et al. A proposed system for the nomenclature of hepatitis C virus genotypes. Hepatology 1994 ; 19:1321-4.
18. Farci P, Alter HJ, Govindarajan S et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992 ; 258:135-40.
19. Widell A, Mansson S, Persson NH et al. Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney. Transplantation 1995 ; 60:642-7.
20. Seelig R, Renz M, Bottner C, Seelig HP. Hepatitis C virus infections in dialysis units : Prevalence of HCV-RNA and antibodies to HCV. Ann Med 1994 ; 26:45-52.
21. Caramelo C, Bartolomé J, Albalate M et al. Undiagnosed hepatitis C virus infection in hemodialysis patients : value of HCV RNA and liver enzyme levels. Kidney Int 1996 ; 50:2027-31.
22. Nousbaum JB, Pol S, Nalpas B et al. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995 ; 122:161-8.
23. Couroucé AM, Bouchardeau F, Chauveau P et al. Hepatitis C (HCV) infection in haemodialysed patients : HCV-RNA and anti-HCV antibodies (third-generation assays). Nephrol Dial Transplant 1995 ; 10:234-9.
24. Oliva JA, Ercilla G, Mallafre JM, Bruguera M, Carrio J, Pereira BJG. Markers of hepatitis C infection among hemodialysis patients with acute and chronic infection : implications for infection control strategies in hemodialysis units. Int J Artif Org 1995 ; 17:73-7.
25. Jadoul M, Cornu C, van Ypersele de Strihou C, the UCL Collaborative Group: Incidence and risk factors for hepatitis C seroconversion in hemodialysis : A prospective study. Kidney Int 1993 ; 44:1322-6.
26. Aeder MI, Shield CF, Tegtmeier GE et al. The incidence and clinical impact of hepatitis C virus (HCV) positive donors in cadaveric transplantation. Transplant Proc 1993 ; 25:1469-71.
27. Pereira BJG, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991 ; 325:454-60.
28. Pirsch JD, Heisey D, D'Allesandro AM et al. Transplantation of hepatitis C (HCV) kidneys: defining the risks. American Society of Transplant Physician, 14 th Annual Meeting, Chicago, 1995, 14-17 May.
29. Morales JM, Campistol JM, Castellano G et al. Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int 1995 ; 47:236-40.
30. Huang CC, Liaw YF, Lai MK et al. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 1992 ; 53:763-5.
31. Pereira BJG, Wright TL, Schmid CH, Levey AS, for the New England Organ Bank Hepatitis C study Group. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 1995 ; 60:799-805.
32. Rostaing L, Izopet J, Duffaut M et al. Liver histology, hepatitis C virus - HCV - genotype and viremia in HCV+ve renal transplant ptients (Abst). J Am Soc Nephrol 1996 ; 7:1940.
33. Rostaing L, Rumeau JL, Alric L et al. Iterative liver biopsies in HCV+ve renal transplant patients. 16th Annual Meeting of the American Society of Transplant Physicians. Chicago, 10-14 May 1997.
34. Orloff SL, Stempel CA, Wright TL et al. Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection. Clin Transplantation 1995 ; 9:119-24.
35. Lim HL, Lau GKK, Davis GL et al. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 1994 ; 106:248-51.
36. Zylberberg H, Carnot F, Mamzer MF et al. Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation. Transplantation 1997 ; 63:158-60.
37. Knoll GA, Tankersley MR, Lee JY et al. The impact of renal transplantation on survival in hepatitis C positive end-stage renal disease patients. Am J Kidney Dis 1997 ; 29:608-14.
38. Brunkhorst R, Kliem V, Koch KM. Recurrence of membranoproliferative glomerulonephritis after renal transplantation in a patient with chronic hepatitis C. Nephron 1996 ; 72:465-7.
39. Roth D, Cirocco R, Zucker K et al. De novo membrano-proliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients. Transplantation 1995 ; 59:1676-82.
40. Sansonno D, Gesualdo L, Manno C et al. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatoloy 1997 ; 25:1237-44.
41. Okada K, Takishita Y, Shimomura H et al. Detection of hepatitis C virus core protein in the glomeruli of patients with membranous glomerulonephritis. Clin Nephrol 1996 ; 45:71-6.
42. Gallay BJ, Alpers CE, Davies CL et al. Glomerulonephritis in renal allografts associated with hepatitis C infection: a possible relationship with transplant glomerulopathy in two cases. Am J Kidney Dis 1995 ; 26:662-7.
43. Cosio FG, Roche Z, Agarwal A et al. Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. Am J Kidney Dis 1996 ; 28:752-8.
44. Cosio FG, Sedmak DD, Henry ML et al. The high prevalence of severe early post transplant renal allograft pathology in hepatitis C positive recipients. Transplantation 1996 ; 62:1054-9.
45. Haboubi NY, Ali HH, Whitwell HL, Ackrill P. Role of endothelial cell injury in the spectrum of azathiopine-induced liver disease after renal transplant : light microscopy and ultrastructural observations. Am J Gastroenterol 1988 ; 83:256-61.
46. Cavalcanti R, Pol S, Carnot F et al. Impact and evolution of peliosis hepatitis in renal transplant recipients. Transplantation 1994 ; 55:315-6.
47. Horina JH, Wirnsberger GH, Kenner L et al. Increased susceptibility for CSA- induced hepatotoxicity in kidney graft recipients with chronic viral hepatitis C. Transplantation 1993 ; 56:1091-4.
48. Sharara AI, Hunt CM, Hanmilton JD. Hepatitis C. Ann Intern Med 1996 ; 125:658-68.
49. Koenig P, Vogel W, Umlauft F et al. Interferon treatment for chronic hepatitis C virus infection in uremic patients. Kidney Int 1994 ; 45:1507-9.
50. Pol S, Thiers V, Carnot F et al. Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients. Kidney Int 1995 ; 47:1412-18.
51. Izopet J, Rostaing L, Moussion F et al. High rate of HCV RNA clearance in hemodialysis patients after alpha-interferon therapy. J Infect Dis 1997 ; 176:1614-17.
52. Thervet E, Pol S, Legendre C et al. Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. Transplantation 1994 ; 58:625-8.
53. Rostaing L, Izopet J, Baron E et al. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 1995 ; 59:1426-31.
54. Rostaing L, Modesto, A, Baron E et al. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. Nephron 1996 ; 74:512-16.
55. Bonkovsky HL. Therapy of hepatitis C: other options. Hepatology 1997 ; 26(Suppl. 1):S143-51.